Cynthia Richards

发表

Postmenopausal Hormone Therapy and Risk of Stroke The Heart and Estrogen-progestin Replacement Study (HERS) Clinical Investigation and Reports

J. Hsia, J. Cauley, E. Barrett-Connor, 2001 .

Postmenopausal Hormone Therapy and Risk of Stroke

J. Hsia, J. Cauley, E. Barrett-Connor, 2001 .

Postmenopausal Hormone Therapy and Risk of Stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

J. Hsia, J. Cauley, E. Barrett-Connor, 2001, Circulation.

An Open-Label Investigation of the Pharmacokinetic Profiles of Lisdexamfetamine Dimesylate and Venlafaxine Extended-Release, Administered Alone and in Combination, in Healthy Adults

K. Lasseter, M. Corcoran, Patrick Martin, 2013, Clinical Drug Investigation.

Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study.

E. Barrett-Connor, K. Yaffe, D. Grady, 2002, The American journal of medicine.

Clinically Relevant Changes in Emotional Expression in Children With ADHD Treated With Lisdexamfetamine Dimesylate

R. Findling, Thomas Babcock, A. Turgay, 2012, Journal of attention disorders.

A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.

M. Trivedi, A. Patkar, Joseph Gao, 2013, The Journal of clinical psychiatry.

Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.

R. Findling, Thomas Babcock, A. Turgay, 2010, Journal of child and adolescent psychopharmacology.

Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults

K. Lasseter, M. Corcoran, Patrick Martin, 2013, Neuropsychiatric disease and treatment.

Treatment outcomes with lisdexamfetamine dimesylate in children who have attention-deficit/hyperactivity disorder with emotional control impairments.

R. Findling, Thomas Babcock, B. Dirks, 2013, Journal of child and adolescent psychopharmacology.

Postmenopausal Hormone Therapy and Risk of Stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

J. Hsia, J. Cauley, E. Barrett-Connor, 2001, Circulation.

A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy

D. Iosifescu, J. Reynolds, E. Sarkis, 2017, Journal of psychopharmacology.

A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults

R. McIntyre, O. Brawman‐Mintzer, R. Weisler, 2018, Journal of clinical psychopharmacology.

Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.

R. McIntyre, O. Brawman‐Mintzer, R. Weisler, 2016, Journal of affective disorders.

Clinically Relevant Changes in Emotional Expression in Children With ADHD Treated With Lisdexamfetamine Dimesylate

R. Findling, Thomas Babcock, A. Turgay, 2012, Journal of attention disorders.